Marquette General Cancer Center

 

Lung/Non-Small Cell

 

 

Study Name - CTSU_E1505

Study Description -
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4cm) IIIA Non-Small Cell Lung Cancer (NSCLC).

IRB Open Date - 08-08-2007

 

Consent-Form

 

Data Privacy Statement for Research Studies

 

 

 

<< Back